A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test

Conditions

• Psoriasis

Interventions

• DRUG: AN2728 Ointment, 5%
• DRUG: AN2728 Ointment, 2%
• DRUG: AN2728 Ointment, 0.5%
• DRUG: AN2728 Ointment Vehicle
• DRUG: Betnesol®-V Creme, 0.1%
• DRUG: Protopic® Ointment, 0.1 %

Sponsor

Pfizer